試す 金 - 無料
Patient saved with robotic partial nephrectomy
Healthcare Radius
|July 2023
Discover how robotic partial nephrectomy saved a 58-year-old patient from Tanzania diagnosed with Bilateral Kidney Cancer
When a patient is diagnosed with advanced and untreatable kidney cancer, it can be a devastating blow. However, the story of one patient's journey shows how technology and innovation can sometimes provide a glimmer of hope. Here, we delve into the remarkable case of a patient who underwent robot-assisted surgery for his previously untreatable kidney cancer, and the incredible success that followed. Despite the odds being stacked against him, this patient's experience highlights the transformative potential of robotic technology in the field of cancer treatment.
Bilateral kidney cancer: A challenge
Bilateral kidney cancer, also known as bilateral renal cell carcinoma, refers to the presence of cancerous tumors in both kidneys. These tumors can be present in both kidneys simultaneously or at different times and can be either synchronous, where tumors are present in both kidneys at the same time, or metachronous, where tumors develop in the second kidney after the first kidney tumor has been treated.
The prevalence of bilateral kidney cancer is relatively low, accounting for approximately 1-5 percent of all renal cell carcinomas (RCCs), which are the most common type of kidney cancer. But most importantly, bilateral kidney cancer (BCC) can present a significant challenge for treatment, as both kidneys may need to be removed or treated with different modalities to ensure the best outcome for the patient.
Advantages of robot-assisted surgery
A study that analyzed efficacy of robot-assisted surgery to treat multiple bilateral kidney tumors, found the procedure was successful in all cases, with no major complications or loss of kidney function.
このストーリーは、Healthcare Radius の July 2023 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Healthcare Radius からのその他のストーリー
Healthcare Radius
VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM
Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.
1 mins
December 2025
Healthcare Radius
A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026
The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.
12 mins
December 2025
Healthcare Radius
FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA
From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.
6 mins
December 2025
Healthcare Radius
ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US
Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.
1 min
December 2025
Healthcare Radius
ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).
1 min
December 2025
Healthcare Radius
SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS
Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.
1 min
December 2025
Healthcare Radius
KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL
Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.
1 min
December 2025
Healthcare Radius
INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH
Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.
1 min
December 2025
Healthcare Radius
OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS
By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”
7 mins
December 2025
Healthcare Radius
MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM
Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.
1 min
December 2025
Translate
Change font size
